Resources with keywords: RT-PCR
2026 Hantavirus Outbreak: Testing for Potential Infection
CDC / Health Alert Network (HAN)
As of 18 May: 10 cases (8 lab-confirmed), 3 deaths. No confirmed U.S. Andes virus cases. Clinical laboratories advised to handle specimens from suspected HPS patients under BSL-2 enhanced precautions (Class II BSC, respirator). Andes virus is NOT a U.S. Select Agent, but laboratory directors should review biosafety risk assessments for specimen processing. Serology (IgM/IgG ELISA) and RT-PCR are diagnostic methods of choice; CDC DHCPP available for testing support.
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing (Website, Publication)
Scientific Reports
21 February 2022
Delpuech O, Douthwaite JA, Hill T, et al.
Heating as the sole method of virus inactivation is ideally suited to streamlined and more rapid workflows such as ‘direct to PCR’ assays that do not involve RNA extraction or chemical neutralisation methods.
